XRP Ledger boom fails to lift price
XRP Ledger recorded strong growth in network activity and tokenisation during the first quarter of 2026, but XRP fell 27.1% over the same period and ended May down a further 6.19%.

Founder and CEO of Grafa, leading the company's vision to democratise financial data and empower investors with innovative tools.
XRP Ledger recorded strong growth in network activity and tokenisation during the first quarter of 2026, but XRP fell 27.1% over the same period and ended May down a further 6.19%.
Kamada (NASDAQ:KMDA) announced Monday that the U.S. Food and Drug Administration has approved its new in-house Rapid Fluorescent Focus Inhibition Test (RFFIT) rabies virus neutralization laboratory at its manufacturing plant in Beit Kama, Israel.
Invivyd (NASDAQ:IVVD) completed enrollment for the pivotal Phase 3 clinical trial of its leading monoclonal antibody candidate, positioning the biotechnology firm to deliver late-stage results later this quarter.
The Cardano Foundation has cancelled its 2026 annual conference after the community rejected a proposal to fund the event using treasury assets for a second time.
FedEx (NYSE:FDX) completed the separation of its less-than-truckload operational unit on Monday, launching FedEx Freight Holding Company (NYSE:FDXF) as an independent, publicly traded entity on the New York Stock Exchange.
Hyperliquid’s HYPE token rose to a new record high after breaking above $70 and touching $74.04 during its latest rally.
Moderna (NASDAQ:MRNA) has expanded its strategic collaboration with the Coalition for Epidemic Preparedness Innovations (CEPI) to accelerate the development of an experimental vaccine targeting the Bundibugyo ebolavirus strain, an aggressive cause of Ebola virus disease for which there are currently no approved or licensed immunizations.
A Bitcoin wallet dating back to 2010 transferred 20 BTC worth approximately $1.47 million on Sunday, ending nearly 16 years of inactivity and drawing attention from blockchain analysts.
Regener8 Resources (ASX:R8R) completed its acquisition of Orichalcum d.o.o, securing full ownership of the Srebrenica North Project.
Memphasys (ASX:MEM) has secured its first commercial partnership in Southeast Asia.